| Dr Mario Jesus De Los Santos Iii, MD | |
|
800 Scott And White Dr, College Station, TX 77845-6440 | |
| (979) 207-4000 | |
| Not Available |
| Full Name | Dr Mario Jesus De Los Santos Iii |
|---|---|
| Gender | Male |
| Speciality | Gastroenterology |
| Experience | 11 Years |
| Location | 800 Scott And White Dr, College Station, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1568806115 | NPI | - | NPPES |
| 10059062200 | Other | TX | SCOTT AND WHITE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | Q8709 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Baylor Scott & White Medical Center- College Stati | College station, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Scott And White Clinic | 8123923604 | 2131 |
News Archive
As the incidence of diabetes and hypertension continues to grow worldwide – and increasing numbers of patients progressing to kidney disease and kidney failure place a financial strain on public health systems – the need for early patient education about kidney disease and treatment options, including home-based treatments, has become critical.
EnGeneIC Ltd., an emerging biopharmaceutical company focused on developing its proprietary EDV™ nanocell platform for the targeted delivery of cancer therapeutics, today announced that the first patient has been dosed in its Phase 1 Tailored-EDV trial. The trial is being conducted at the Northern Cancer Institute in Sydney, Australia.
In this Financial Times opinion piece, journalist Andrew Jack examines the challenges of family planning in some poorer countries, where public health programs "risk adding to population pressures and inadvertently setting back development," writing, "In a number of countries, notably in central and western Africa, health programs have contributed to cutting infant mortality rates, but birth rates have continued to remain stubbornly high. The unintended consequence is a fast-growing population that adds further pressure on poor families and fragile environments."
Scientists at Brunel University London have developed a system for Parkinson's sufferers to counter two of the most common and distressing symptoms of the degenerative disease.
› Verified 3 days ago
| Entity Name | Scott & White Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093779704 PECOS PAC ID: 8123923604 Enrollment ID: O20031223000640 |
News Archive
As the incidence of diabetes and hypertension continues to grow worldwide – and increasing numbers of patients progressing to kidney disease and kidney failure place a financial strain on public health systems – the need for early patient education about kidney disease and treatment options, including home-based treatments, has become critical.
EnGeneIC Ltd., an emerging biopharmaceutical company focused on developing its proprietary EDV™ nanocell platform for the targeted delivery of cancer therapeutics, today announced that the first patient has been dosed in its Phase 1 Tailored-EDV trial. The trial is being conducted at the Northern Cancer Institute in Sydney, Australia.
In this Financial Times opinion piece, journalist Andrew Jack examines the challenges of family planning in some poorer countries, where public health programs "risk adding to population pressures and inadvertently setting back development," writing, "In a number of countries, notably in central and western Africa, health programs have contributed to cutting infant mortality rates, but birth rates have continued to remain stubbornly high. The unintended consequence is a fast-growing population that adds further pressure on poor families and fragile environments."
Scientists at Brunel University London have developed a system for Parkinson's sufferers to counter two of the most common and distressing symptoms of the degenerative disease.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mario Jesus De Los Santos Iii, MD Po Box 844658, Dallas, TX 75284-4658 Ph: (254) 724-8800 | Dr Mario Jesus De Los Santos Iii, MD 800 Scott And White Dr, College Station, TX 77845-6440 Ph: (979) 207-4000 |
News Archive
As the incidence of diabetes and hypertension continues to grow worldwide – and increasing numbers of patients progressing to kidney disease and kidney failure place a financial strain on public health systems – the need for early patient education about kidney disease and treatment options, including home-based treatments, has become critical.
EnGeneIC Ltd., an emerging biopharmaceutical company focused on developing its proprietary EDV™ nanocell platform for the targeted delivery of cancer therapeutics, today announced that the first patient has been dosed in its Phase 1 Tailored-EDV trial. The trial is being conducted at the Northern Cancer Institute in Sydney, Australia.
In this Financial Times opinion piece, journalist Andrew Jack examines the challenges of family planning in some poorer countries, where public health programs "risk adding to population pressures and inadvertently setting back development," writing, "In a number of countries, notably in central and western Africa, health programs have contributed to cutting infant mortality rates, but birth rates have continued to remain stubbornly high. The unintended consequence is a fast-growing population that adds further pressure on poor families and fragile environments."
Scientists at Brunel University London have developed a system for Parkinson's sufferers to counter two of the most common and distressing symptoms of the degenerative disease.
› Verified 3 days ago
Joseph Jason Roman, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1602 Rock Prairie Rd, Suite 4880, College Station, TX 77845 Phone: 979-796-1111 Fax: 979-764-1164 | |
Ashley Annly Liou, DO Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 700 Scott And White Dr, College Station, TX 77845 Phone: 979-207-0100 Fax: 979-207-2161 | |
Rajpreet Kaur Singh, D.O. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1725 Birmingham Rd Ste 200, College Station, TX 77845 Phone: 979-696-8000 Fax: 979-696-8100 | |
Dr. Natraj Aiyappan Shanmugam, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1602 Rock Prairie Rd, Suite 210, College Station, TX 77845 Phone: 979-696-5663 Fax: 979-694-1319 | |
Kaycee Leigh Weaver, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 700 Scott And White Dr, College Station, TX 77845 Phone: 979-207-0100 | |
Dr. Daniel Philip Stagg Iii, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 800 Scott And White Dr, College Station, TX 77845 Phone: 979-207-4000 Fax: 979-207-4562 | |
Dr. Thomas H. Meade, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1721 Birmingham Rd Ste 202, College Station, TX 77845 Phone: 979-446-0373 |